The role of oncogene c-MYC in the development and progression of non-alcoholic fatty liver disease in mice

Nonalcoholic fatty liver disease (NAFLD) has rapidly risen as one of the leading etiologies for HCC and represents a large societal and health problem. Many factors are responsible for the high risk of NAFLD and NAFLD-related HCC development. Lately, oncogenes have been suggested to be determinant.T...

Descripción completa

Detalles Bibliográficos
Autor: Guo, Feifei
Tipo de recurso: tesis doctoral
Fecha de publicación:2021
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/5705
Acceso en línea:https://hdl.handle.net/20.500.14352/5705
Access Level:acceso abierto
Palabra clave:616.36(043.2)
Liver (diseases)
Hígado (enfermedades)
Gastroenterología y hepatología
3205.03 Gastroenterología
Descripción
Sumario:Nonalcoholic fatty liver disease (NAFLD) has rapidly risen as one of the leading etiologies for HCC and represents a large societal and health problem. Many factors are responsible for the high risk of NAFLD and NAFLD-related HCC development. Lately, oncogenes have been suggested to be determinant.The oncogene activation of c-MYC can induce genetic instability, promote the cell cycle, and increase proliferation, thereby accelerating tumor progression, studies also observed a significant c-MYC over expression in livers with CLD including hepatic hepatitis, fibrosis and cirrhosis, and also indicates the overexpression of c-MYC might increase the susceptibility of liver cells to develop HCC; however, their role still remains unknown. Here we overall aimed to analyse the impact of the proto-oncogene c-MYC in the development of murine NAFLD and NAFLD-associated HCC...